Dose-Response Moringa Oleifera Extracts on Lactation Outcomes In Breastfeeding Women
- 1Health Polytechnic of Semarang
- 2Department of Public Health Nutrition, Universitas Diponegoro, Semarang, Indonesia
Abstract
Introduction: Herbal galactagogues such as Moringa oleifera are traditionally used to enhance breast milk production. However, evidence regarding optimal dosage is limited. This study aimed to evaluate the effects of three different doses of Moringa oleifera extract (250 mg, 650 mg, and 800 mg) on breast milk production in breastfeeding mothers. Methods: a quasi-experimental pretest posttest was conducted among 89 postpartum women from three Primary Health Centre areas in Semarang, Central Java, Indonesia. Participants received 250 mg (n=28), 650 mg (n=30), or 800 mg (n=31) of Moringa oleifera extract once daily for 14 days. Outcomes were infant weight gain, bowel movement frequency, and urination frequency. Data were collected from October 2024 to March 2025 and analysed using paired t tests and Kruskal-Wallis tests (p<0.05). Results: All dosage groups showed improvements in indicators of breast milk production. No statistically significant differences were observed between groups (p>0,05). The 650 mg group recorded the highest mean infant weight gain, whereas the 250 mg group showed the greatest increases in bowel movements and urination frequency. Conclusions: Moringa oleifera extract at 250, 650, and 800 mg/day over 14 days supported breast-milk production. Further studies are needed to clarify the dose response relationship.
Related
- Evaluation of the antifungal activity of Moringa oleifera leaf and stem bark extracts against Fusarium species causing potato wilt
- Combination of Ulva lactuca and Moringa oleifera Extracts as Additives in Salt Production and Evaluation of Their Activities
- Antibacterial and Anti-Inflammatory Activities of Moringa oleifera: Extracts, Bioactive Compounds, and Mechanisms.
- Genome-wide identification of aquaporin family in Camellia oleifera and their response characteristics to drought stress
- Carry-over influence of maternal L-carnitine during gestation and lactation on metabolic response of New Zealand neonatal rabbits.
BibTeX
@article{irmawati2026doseresponse,
title = {{Dose-Response Moringa Oleifera Extracts on Lactation Outcomes In Breastfeeding Women}},
author = {Irmawati Irmawati and Mohammad Zen Rahfiludin},
journal = {KEMAS: Jurnal Kesehatan Masyarakat},
year = {2026},
month = jul,
doi = {10.15294/kemas.v21i4.40624},
url = {https://doi.org/10.15294/kemas.v21i4.40624},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dose-Response Moringa Oleifera Extracts on Lactation Outcomes In Breastfeeding Women
AU - Irmawati Irmawati
AU - Mohammad Zen Rahfiludin
PY - 2026
DA - 2026/07/01
JO - KEMAS: Jurnal Kesehatan Masyarakat
DO - 10.15294/kemas.v21i4.40624
UR - https://doi.org/10.15294/kemas.v21i4.40624
AB - Introduction: Herbal galactagogues such as Moringa oleifera are traditionally used to enhance breast milk production. However, evidence regarding optimal dosage is limited. This study aimed to evaluate the effects of three different doses of Moringa oleifera extract (250 mg, 650 mg, and 800 mg) on breast milk production in breastfeeding mothers. Methods: a quasi-experimental pretest posttest was conducted among 89 postpartum women from three Primary Health Centre areas in Semarang, Central Java, Indonesia. Participants received 250 mg (n=28), 650 mg (n=30), or 800 mg (n=31) of Moringa oleifera extract once daily for 14 days. Outcomes were infant weight gain, bowel movement frequency, and urination frequency. Data were collected from October 2024 to March 2025 and analysed using paired t tests and Kruskal-Wallis tests (p<0.05). Results: All dosage groups showed improvements in indicators of breast milk production. No statistically significant differences were observed between groups (p>0,05). The 650 mg group recorded the highest mean infant weight gain, whereas the 250 mg group showed the greatest increases in bowel movements and urination frequency. Conclusions: Moringa oleifera extract at 250, 650, and 800 mg/day over 14 days supported breast-milk production. Further studies are needed to clarify the dose response relationship.
SN - 1858-1196
SN - 2355-3596
ER -